1. Home
Lipogems for Urogenital Atrophy Treatment - AICPE 2018

Research

Lipogems for Urogenital Atrophy Treatment - AICPE 2018

A clinical study conducted by Prof. Carlo Tremolada and Dr. G. A. Casarotti on urogenital atrophy treatment using the Lipogems method was presented at the AICPE National Congress in Florence. The study, initiated in 2015, involved 32 women who received a single Lipogems treatment, demonstrating significant efficacy in gynecological applications. A similar project is ongoing at Brown University's urogynecology department in Providence in collaboration with Istituto Image.

Urogenital atrophy is a benign degenerative process affecting vaginal tissues and urethra, caused by depleted estrogen production. The condition typically progresses over time, leading to complete tissue atrophy.

Vaginal Symptoms

Common symptoms include vaginal dryness, dyspareunia, burning sensation, itching, and reduced clitoral and vaginal sensitivity. Increased collagen turnover reduces vaginal structural support, promoting vaginal prolapse. Reduced glycogen production leads to elevated vaginal pH, decreased lactobacillary flora, and increased coliform bacteria causing infections.

Urethral Impact

The urethra contains high levels of estrogen receptors due to its embryonic origin. Hypoestrogensim results in dysuria, bladder tenesmus, urinary burning, and stress urinary incontinence.

Lipogems Treatment Outcomes

The study monitored patients at 3, 6, 9, 12, 18, 24, and 36 months post-treatment. Initial findings showed significant symptom improvement by 6 months, with 25 patients reporting complete pain resolution at 12 months. Of 9 patients reaching the 36-month follow-up, only 2 reported mild residual symptoms.

Laboratory analysis demonstrated restoration of vaginal pH from 6.0 ± 0.2 to 4.1 ± 0.2 and reestablishment of lactobacillary flora at 12-36 months post-treatment.

Conclusion

The Lipogems treatment demonstrated significant efficacy in addressing urogenital atrophy symptoms in postmenopausal women. Benefits included pain reduction, improved urinary symptoms, and restoration of normal vaginal flora and pH. The treatment's regenerative properties showed lasting effects through the 36-month follow-up period.

Attention

The information available on the website istitutoimage.it is intended solely for informational purposes and is in no way a substitute for specialist medical advice. The contents are drafted in compliance with Art. 56 of the FNOMCeO Code of Ethics and the Ministerial Circular dated 18/12/2024. The information published has been prepared by qualified doctors and surgeons and is solely for educational purposes:

  • it does not in any way constitute a diagnosis;
  • it does not replace the direct doctor-patient relationship;
  • it must not be used as a prescription for treatments or as a basis for autonomous therapeutic decisions.

To assess suitability for aesthetic medicine treatments or plastic surgery procedures, a specialist medical consultation is always required.

For any questions, the Image Regenerative Clinic team is available with no obligation. Read the full Disclaimer.

Mission

This website is aimed at users seeking qualified and up-to-date information about regenerative aesthetic medicine, plastic surgery and longevity programs. Its contents are intended to provide general knowledge and are not a substitute for the doctor-patient relationship. Image Regenerative Clinic is committed to offering scientifically supported treatments and therapies with the utmost transparency and in full compliance with current regulations.

Website Authors

Dr. Carlo Tremolada – OMCEO Milan registration no. 30098  All the contents and images on this website have been written, reviewed and approved by the internal Medical-Scientific Committee coordinated by Dr. Carlo Tremolada, in compliance with Art. 56 of the FNOMCeO Code of Ethics and current regulations on healthcare advertising.

Website Ownership

The website istitutoimage.it is owned by Image Regenerative Clinic S.r.l.

It does not contain banner advertising, does not host sponsored content and does not benefit from grants or revenue from external advertising.